Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences

被引:1
|
作者
Weis, Michael [1 ]
Weis, Mara [1 ]
机构
[1] Univ Munich, Krankenhaus Neuwittelsbach, Dept Internal Med 1, D-80639 Munich, Germany
关键词
CARDIAC ALLOGRAFT VASCULOPATHY; CORONARY ENDOTHELIAL DYSFUNCTION; HEART-TRANSPLANTATION; INTERNATIONAL SOCIETY; LUNG TRANSPLANTATION; VASOMOTOR FUNCTION; PROGNOSTIC VALUE; ARTERY-DISEASE; DONOR; ACTIVATION;
D O I
10.1097/TP.0000000000004853
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cardiac allograft vasculopathy (CAV) is one of the leading causes of graft failure and death after heart transplantation. Alloimmune-dependent and -independent factors trigger the pathogenesis of CAV through activation of the recipients' (and to a lesser extent donor-derived) immune system. Early diagnosis of CAV is complicated by the lack of clinical symptoms for ischemia in the denervated heart, by the impact of early functional coronary alterations, by the insensitivity of coronary angiography, and by the involvement of small intramyocardial vessels. CAV in general is a panarterial disease confined to the allograft and characterized by diffuse concentric longitudinal intimal hyperplasia in the epicardial coronary arteries and concentric medial disease in the microvasculature. Plaque composition in CAV may include early fibrous and fibrofatty tissue and late atheromatous calcification. In contrast, native coronary atherosclerosis usually develops over decades, is focal, noncircumferential, and typically diminishes proximal parts of the epicardial vessels. The rapid and early development of CAV has an adverse prognostic impact, and current prevention and treatment strategies are of limited efficacy compared with established strategies in native atherosclerosis. Following acute coronary syndromes, patients after heart transplantation were more likely to have accompanying cardiogenic shock and higher mortality compared with acute coronary syndromes patients with native hearts.
引用
收藏
页码:1342 / 1349
页数:8
相关论文
共 50 条
  • [31] Chemokines and Transplant Vasculopathy
    Belperio, John A.
    Ardehali, Abbas
    CIRCULATION RESEARCH, 2008, 103 (05) : 454 - 466
  • [32] Cardiac allograft vasculopathy: Differences in de novo and maintenance heart transplant recipients
    Frigerio, Maria
    Garascia, Andrea
    Roubina, Elena
    Distefano, Giada
    Orrego, Pedro Silva
    Colombo, Paola
    Bruschi, Giuseppe
    Vitali, Ettore
    TRANSPLANTATION, 2006, 82 (08) : S5 - S12
  • [33] Mechanisms of transplant vasculopathy
    Baron, H
    Plenz, G
    Deng, MC
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (41) : 2193 - 2197
  • [34] Transplant coronary vasculopathy
    Salpy V. Pamboukian
    Maria Rosa Costanzo
    Current Treatment Options in Cardiovascular Medicine, 2001, 3 (1) : 55 - 63
  • [35] Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences
    Ashina, Hakan
    Christensen, Rune Hackert
    Ashina, Messoud
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [36] Intertemporal Decisions From Experience Versus Description: Similarities and Differences
    Shavit, Yael
    Roth, Yefim
    Busemeyer, Jerome
    Teodorescu, Kinneret
    DECISION-WASHINGTON, 2022, 9 (02): : 131 - 152
  • [37] TPP versus ECFA: Similarities, Differences, and China's Strategies
    Huang, Jie
    CHINA REVIEW-AN INTERDISCIPLINARY JOURNAL ON GREATER CHINA, 2012, 12 (02): : 85 - 109
  • [38] Cardiac transplant vasculopathy
    Tobis, Jonathan M.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017, 90 (01) : 56 - 57
  • [39] Cardiac transplant vasculopathy
    Aranda, JM
    Hill, J
    CHEST, 2000, 118 (06) : 1792 - 1800
  • [40] Innovation in Construction Techniques on Earth versus Space: Similarities and Differences
    Subedi, Sudip
    Pradhananga, Nipesh
    EARTH AND SPACE 2021: SPACE EXPLORATION, UTILIZATION, ENGINEERING, AND CONSTRUCTION IN EXTREME ENVIRONMENTS, 2021, : 1220 - 1230